Pharmacokinetics of phenobarbital in horses after single and repeated oral administration of the drug
Six healthy mature horses were orally administered a single dose of phenobarbital (26 mg/kg of body weight), then multiple doses (13 mg/kg) orally for 42 consecutive days. Seventeen venous blood samples were collected from each horse after the single dose study and again after the last dose on day 4...
Saved in:
Published in | American journal of veterinary research Vol. 53; no. 5; p. 706 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.1992
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Six healthy mature horses were orally administered a single dose of phenobarbital (26 mg/kg of body weight), then multiple doses (13 mg/kg) orally for 42 consecutive days. Seventeen venous blood samples were collected from each horse after the single dose study and again after the last dose on day 42. Plasma phenobarbital concentration was determined by use of a fluorescence assay validated for horses. Additional blood samples (n = 11) were collected on days 8 and 25 to determine peak and trough concentrations, as well as total body clearance. Phenobarbital disposition followed a one-compartment model. Mean kinetic variables after single and repeated orally administered doses (42 days) were: elimination half-life = 24.2 +/- 4.7 and 11.2 +/- 2.3 hours, volume of distribution = 0.960 +/- 0.060 and 0.914 +/- 0.119 L/kg, and clearance = 28.2 +/- 5.1 and 57.3 +/- 9.6 ml/h/kg, respectively. Results indicated that significant (P 0.05) difference in half-life and oral clearance existed between single and repeated dosing. The significant decrease in half-life after repeated dosing with phenobarbital may be indicative of enzyme induction. Significant difference was not observed between baseline serum enzyme concentration and concentration measured on day 42, except for gamma-glutamyltransferase activity, which was significantly increased on day 42 in 3 of the 6 horses. On the basis of increases in oral clearance observed over 42 days, dose adjustments may be required. By days 25 to 42, pharmacokinetic values indicated that dosages of phenobarbital between 25 and 27 mg/kg administered orally every 24 hours may be needed to maintain steady state plasma concentration of phenobarbital at 20 micrograms/ml of plasma in mature horses |
---|---|
AbstractList | Six healthy mature horses were orally administered a single dose of phenobarbital (26 mg/kg of body weight), then multiple doses (13 mg/kg) orally for 42 consecutive days. Seventeen venous blood samples were collected from each horse after the single dose study and again after the last dose on day 42. Plasma phenobarbital concentration was determined by use of a fluorescence assay validated for horses. Additional blood samples (n = 11) were collected on days 8 and 25 to determine peak and trough concentrations, as well as total body clearance. Phenobarbital disposition followed a one-compartment model. Mean kinetic variables after single and repeated orally administered doses (42 days) were: elimination half-life = 24.2 +/- 4.7 and 11.2 +/- 2.3 hours, volume of distribution = 0.960 +/- 0.060 and 0.914 +/- 0.119 L/kg, and clearance = 28.2 +/- 5.1 and 57.3 +/- 9.6 ml/h/kg, respectively. Results indicated that significant (P 0.05) difference in half-life and oral clearance existed between single and repeated dosing. The significant decrease in half-life after repeated dosing with phenobarbital may be indicative of enzyme induction. Significant difference was not observed between baseline serum enzyme concentration and concentration measured on day 42, except for gamma-glutamyltransferase activity, which was significantly increased on day 42 in 3 of the 6 horses. On the basis of increases in oral clearance observed over 42 days, dose adjustments may be required. By days 25 to 42, pharmacokinetic values indicated that dosages of phenobarbital between 25 and 27 mg/kg administered orally every 24 hours may be needed to maintain steady state plasma concentration of phenobarbital at 20 micrograms/ml of plasma in mature horses Six healthy mature horses were orally administered a single dose of phenobarbital (26 mg/kg of body weight), then multiple doses (13 mg/kg) orally for 42 consecutive days. Seventeen venous blood samples were collected from each horse after the single dose study and again after the last dose on day 42. Plasma phenobarbital concentration was determined by use of a fluorescence assay validated for horses. Additional blood samples (n = 11) were collected on days 8 and 25 to determine peak and trough concentrations, as well as total body clearance. Phenobarbital disposition followed a one-compartment model. Mean kinetic variables after single and repeated orally administered doses (42 days) were: elimination half-life = 24.2 +/- 4.7 and 11.2 +/- 2.3 hours, volume of distribution = 0.960 +/- 0.060 and 0.914 +/- 0.119 L/kg, and clearance = 28.2 +/- 5.1 and 57.3 +/- 9.6 ml/h/kg, respectively. Results indicated that significant (P less than 0.05) difference in half-life and oral clearance existed between single and repeated dosing. The significant decrease in half-life after repeated dosing with phenobarbital may be indicative of enzyme induction. Significant difference was not observed between baseline serum enzyme concentration and concentration measured on day 42, except for gamma-glutamyltransferase activity, which was significantly increased on day 42 in 3 of the 6 horses. On the basis of increases in oral clearance observed over 42 days, dose adjustments may be required. |
Author | Ravis, W.R Schumacher, J Pedersoli, W.M Spano, J.S Nostrandt, A.C Krista, L.M Knox, D.A. (Auburn University, AL) |
Author_xml | – sequence: 1 fullname: Knox, D.A. (Auburn University, AL) – sequence: 2 fullname: Ravis, W.R – sequence: 3 fullname: Pedersoli, W.M – sequence: 4 fullname: Spano, J.S – sequence: 5 fullname: Nostrandt, A.C – sequence: 6 fullname: Krista, L.M – sequence: 7 fullname: Schumacher, J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/1524295$$D View this record in MEDLINE/PubMed |
BookMark | eNotj11LwzAUhoNM5jb9A4qQP9CanDRZcynDLxgo6K7LaXu6Zq5pSTrBf-9ku3ovnpcHnjmb-N4TY3dSpJAZ8YC7n5BKayHVKhU6XQpzwWbSZirRJpcTNhNCQGJNpq_YPMadEBJyqadsKjVkYPWM0UeLocOq_3aeRldF3jd8aMn3JYbSjbjnzvO2D5Eix2akwKPz2z1x9DUPNBCOVPM-HI9Yd867OAYcXe__RWNLvA6H7TW7bHAf6ea8C7Z5fvpavSbr95e31eM6qZTJxsTmAstMKKWNVMIYsABl0zSVlSSAVC5hCYZAaVVpXdta1RotUCUAcswsLNj9yTscyo7qYgiuw_BbnHOP_PbEG-wL3AYXi82nlVaAzuEPIW1izA |
CitedBy_id | crossref_primary_10_1016_S1534_7516_03_00033_7 crossref_primary_10_1002_dta_174 |
ContentType | Journal Article |
DBID | FBQ CGR CUY CVF ECM EIF NPM |
DOI | 10.2460/ajvr.1992.53.05.706 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 1943-5681 |
ExternalDocumentID | 1524295 US9190258 |
Genre | Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: FDA HHS grantid: FDA-U-000059-02 |
GroupedDBID | --- -~X .GJ 0VX 1KJ 23M 41~ 53G 5GY 5RE 6J9 AAVBQ ABCQX ABPPZ ABPTK ACB ACGFO AENEX AI. ALMA_UNASSIGNED_HOLDINGS CS3 EBS EJD F5P FBQ GROUPED_DOAJ OHT P2P QJJ SJN UGJ UHB VH1 WH7 YQJ ZGI ZXP ~KM CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-c364t-980ab403356130662922bfffc91e02e3812726e2353c55d9d3d5a92ec0228a492 |
ISSN | 0002-9645 |
IngestDate | Sat Sep 28 07:25:43 EDT 2024 Wed Dec 27 19:15:38 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c364t-980ab403356130662922bfffc91e02e3812726e2353c55d9d3d5a92ec0228a492 |
Notes | L70 9190258 |
OpenAccessLink | https://avmajournals.avma.org/downloadpdf/view/journals/ajvr/53/5/ajvr.1992.53.05.706.pdf |
PMID | 1524295 |
ParticipantIDs | pubmed_primary_1524295 fao_agris_US9190258 |
PublicationCentury | 1900 |
PublicationDate | 1992-05-01 |
PublicationDateYYYYMMDD | 1992-05-01 |
PublicationDate_xml | – month: 05 year: 1992 text: 1992-05-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of veterinary research |
PublicationTitleAlternate | Am J Vet Res |
PublicationYear | 1992 |
SSID | ssj0012815 |
Score | 1.4398046 |
Snippet | Six healthy mature horses were orally administered a single dose of phenobarbital (26 mg/kg of body weight), then multiple doses (13 mg/kg) orally for 42... |
SourceID | pubmed fao |
SourceType | Index Database Publisher |
StartPage | 706 |
SubjectTerms | Absorption Administration, Oral Animals CABALLOS CHEVAL FARMACOLOGIA FENOBARBITAL Half-Life Horses - metabolism Liver - drug effects METHODE D'APPLICATION METODOS DE APLICACION PHARMACOLOGIE PHENOBARBITAL Phenobarbital - administration & dosage Phenobarbital - adverse effects Phenobarbital - pharmacokinetics Tissue Distribution |
Title | Pharmacokinetics of phenobarbital in horses after single and repeated oral administration of the drug |
URI | https://www.ncbi.nlm.nih.gov/pubmed/1524295 |
Volume | 53 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELYSEFIvCAIV5VH5wHXLrl-7PvKqKlCrAg30Ftleuy2PTRSlPfAX-NPMrJ3sJhTxuKwiO7J2Zz6Px-OZz4Q8NTBnlC1CVhqRZ6IILjO-llkVgrBKaGMqrB0-PFIHY_HmVJ4OBj96WUuXC7vnvl9bV_I_WoU20CtWyf6DZleDQgP8Bv3CEzQMz7_S8XHinf4CrmJLt4zpy-e-gTk6t3gbCEYzzqeYppEuA8fIwNd4YjD3M7DD4G-2NfpmjUR3mTlQzy_P-u7r6nynRzhxhQk1sao3MQetIsxvm7i2veoipu-XrAafulTFYyS0AEldxPbuhmOwVPFgKAVo61Sux7pcwJ7F1SpSRi4tbqQHTsiSPfNZtuwDv5h1JhTmQZrPV3OsrmR7kiPd6sa_QTezb62mwSeBZVb-sXODaTv1DMmwrNBYHmHgJx1IsSpdhpE-JxJY4Ys9u-a1tsitNBi4LMFMN_Ysre9ycofcTpsO-jwi6C4Z-GZERh9XiqOHKcPiHvGbmKLTQNcwRS8aGjFFW0zRiCkKmKJLTFHEFF3HFA4EmKKIqftkvP_65OVBlq7iyBxXYpHpKjdW5Jy3-02lmGbMhhCcLnzOPLh9rGTKMy65k7LWNa-l0cw7pFcyQrNtcqOZNv4BodqZ3Pm8dB7Ng7EGJOu89nVla84Lt0NGILGJOYNFbjL-oAs8CK92yHaU4GQWWVgmScAPf9fxiGx1gHxMbgaY9P4JeJALu0uG-y_e7bYa_gnD6nHv |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics+of+phenobarbital+in+horses+after+single+and+repeated+oral+administration+of+the+drug&rft.jtitle=American+journal+of+veterinary+research&rft.au=Knox%2C+D+A&rft.au=Ravis%2C+W+R&rft.au=Pedersoli%2C+W+M&rft.au=Spano%2C+J+S&rft.date=1992-05-01&rft.issn=0002-9645&rft.volume=53&rft.issue=5&rft.spage=706&rft_id=info:doi/10.2460%2Fajvr.1992.53.05.706&rft_id=info%3Apmid%2F1524295&rft_id=info%3Apmid%2F1524295&rft.externalDocID=1524295 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9645&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9645&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9645&client=summon |